Neuren Pharmaceuticals Limited

OTCPK:NURP.F Stock Report

Market Cap: US$971.7m

Neuren Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:NURP.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 24BuyUS$66,879Joe BasileIndividual6,406US$10.44
17 Jul 24BuyUS$88,856,119Milford Asset Management, LTDCompany8,499,600US$10.45
17 Jul 24SellUS$88,536,417Milford Asset Management, LTDCompany9,003,256US$9.83
11 Jun 24BuyUS$64,277Joe BasileIndividual5,000US$12.86

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NURP.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies404,0720.316%
Individual Insiders4,235,3313.31%
Private Companies12,359,0129.67%
Institutions20,459,53216%
General Public90,324,86470.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 29.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.98%
The Vanguard Group, Inc.
6,367,361US$48.4m0.45%no data
4.74%
Milford Asset Management, LTD
6,058,321US$46.1m-7.68%0.95%
3.23%
Cameron Richard Pty Limited
4,123,084US$31.4m0%no data
2.06%
Stuart Andrew Pty. Ltd.
2,633,787US$20.0m0%no data
1.95%
Norges Bank Investment Management
2,486,288US$18.9m0%no data
1.89%
Trevor Scott
2,414,784US$18.4m0%no data
1.81%
BlackRock, Inc.
2,314,916US$17.6m4.25%no data
1.46%
Smithley Super Pty. Limited
1,870,000US$14.2m0%no data
1.38%
Linwierik Super Pty. Limited
1,761,385US$13.4m0%no data
0.72%
BetaShares Capital Limited
917,270US$7.0m7.46%0.04%
0.59%
First Colby Co Pty Ltd
750,000US$5.7m0%no data
0.59%
Mjhft Pty Ltd
750,000US$5.7m0%no data
0.53%
Robin Congreve
671,637US$5.1m0%no data
0.41%
State Street Global Advisors, Inc.
522,065US$4.0m-0.34%no data
0.38%
Goldman Sachs Asset Management, L.P.
481,489US$3.7m369%no data
0.37%
Emancipayte Pty ltd
470,756US$3.6m0%no data
0.33%
Netwealth Investments Ltd.
421,309US$3.2m0%0.04%
0.32%
He Zhao
405,000US$3.1m0%no data
0.32%
Pfizer Inc.
404,072US$3.1m0%no data
0.31%
Jonathan Pilcher
398,207US$3.0m0%no data
0.31%
Jupiter Fund Management Plc
396,906US$3.0m0%0.01%
0.21%
Patrick Donald Davies
264,634US$2.0m0%no data
0.16%
Charles Schwab Investment Management, Inc.
210,311US$1.6m4.59%no data
0.12%
Nordea Investment Management, AB
149,709US$1.1m0%no data
0.12%
Dimensional Fund Advisors LP
149,393US$1.1m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 05:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neuren Pharmaceuticals Limited is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Thomas WakimBell Potter
Tara SperanzaBell Potter